Stocksigma LogoStocksigma Logo

IOL Chemicals Receives EDQM CEP Approval for Fenofibrate Process II

The European Directorate for the Quality of Medicines & HealthCare (EDQM) granted a Certificate of Suitability (CEP) on 24th Sep'26 to IOL Chemicals and

IOL Chemicals Receives EDQM CEP Approval for Fenofibrate Process II

IOL Chemicals & Pharmaceuticals Ltd · Others (Uncategorized) · 25 Sept 2026, 6:42 pm

IOL Chemicals Receives EDQM CEP Approval for Fenofibrate Process II The European Directorate for the Quality of Medicines & HealthCare (EDQM) granted a Certificate of Suitability (CEP) on 24th Sep'26 to IOL Chemicals and Pharmaceuticals Limited for its API product "FENOFIBRATE – Process II". This approval comes in addition to the company's existing CEP for Fenofibrate. Process II was developed to meet specific customer requirements, strengthening IOL Chemicals' regulatory compliance and expanding its supply capabilities across regulated markets.

Original exchange filing (PDF)

More announcements from IOL Chemicals & Pharmaceuticals Ltd

All IOL Chemicals & Pharmaceuticals Ltd announcements